Advisory, research, historical archives, and industry-leadingdatasets now available in one destination Closed-End Fund Advisors Inc. (“CEF Advisors”), a fee-only SEC-registered investment advisory firm specializing in closed-end funds (CEFs), business development companies (BDCs), interval funds, and tender-offer funds, today announced the launch of its redesigned website at www.CEFData.com. The new platform unites the firm's advisory services […]

PolyAI, a leader in enterprise conversational AI, today announced it has been recognized in multiple 2025 Gartner reports, including the Hype Cycle for Customer Service and Support Technologies (July 2025), the Hype Cycle for CRM Technologies (July 2025), and the Hype Cycle for Strategic Cost Optimization (August 2025). https://mma.prnewswire.com/media/2762293/PolyAI_Logo.jpg Gartner Hype Cycles provide a graphic

CIBC (TSX: CM) (NYSE: CM) today announced that Marianne Harrison will be joining its Board of Directors effective September 8, 2025. Ms. Harrison was previously President and Chief Executive Officer at John Hancock as well as President and Chief Executive Officer of Manulife Canada and brings significant experience in the financial services sector having held

Community-led grant honors Indigenous creativity, cultural leadership, and artistic resilience across the Pacific Creative West, a regional arts nonprofit, is proud to announce the culmination of the first ever Pacific Jurisdictions Artist Fund. The fund will provide 45 artists and cultural practitioners from American Samoa, Guam, and the Commonwealth of the Northern Mariana Islands (Saipan,

Nauticus Robotics, Inc.(NASDAQ: KITT, “Nauticus” or the “Company”) today announced that it will proceed with a 1-for-9 reverse stock split (“Reverse Split”) of its outstanding shares of common stock (“Common Stock”) following approval by its Board of Directors and stockholders. This ratio is within the range approved by stockholders at the annual meeting of the

Obstructive sleep apnea (OSA) is a hidden driver of chronic disease and skyrocketing healthcare costs, with untreated cases costing the US economy $150 billion annually. Vivos Therapeutics' integrated, non-invasive solutions challenge outdated paradigms, offering a proactive and cost-effective approach to OSA treatment. Obstructive sleep apnea (OSA) is wreaking havoc on individuals and healthcare systems alike,

This September, Anycubiccelebrates its 10th anniversary, a milestone that marks a decade of technological advancement and a shared journey with a global community of creators. What began as a small team assembling its first prototype in a humid Shenzhen office has grown into a leading force in consumer 3D printing, empowering innovation in over 200

(PinkSheets:BSEM),(Pinksheets:BSEM), POMPANO BEACH, Fla., Sept. 02, 2025 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announced that Company management will present at the following upcoming investor conferences being held in New York, NY. Morgan Stanley Global

(NASDAQ:OTLK),(NASDAQ:OTLKW), ISELIN, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on optimizing the standard of care for bevacizumab for the treatment of retina diseases, today announced that a Type A Meeting request has been submitted to the U.S. Food and Drug Administration (FDA) to discuss the complete

(NYSE:KLC), NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP is informing investors about a class action lawsuit against KinderCare Learning Companies, Inc. (NYSE: KLC) (“KinderCare”). The lawsuit addresses alleged violations of the Securities Act of 1933 related to KinderCare's October 2024 initial public offering (“IPO”). These allegations stem